DigitalOcean Holdings, Inc.
DOCN is executing well into an AI-led acceleration, but at $145.41 the stock already discounts far more than management has formally guided, leaving a stretched setup against a $78.57 base value and a rich premium to peers.
DOCN is running better than it was two years ago. The company has moved from a steady-growth cloud niche story into an AI-capacity and inference demand story, and the numbers show it. Q2 revenue was $281M, above guidance. Incremental ARR was $93M, a record. AI customer ARR hit $234M, up 212% y/y. Management raised FY2026 revenue guidance to $1.17B-$1.18B and now expects 35%+ growth by Q4 2026. This is not a case of deteriorating operations or missed guidance.
The problem is the stock price. At $145.41, the market is paying a valuation that leaves little room for friction. The stock sits at 51.64x earnings and 13.46x sales, both rich versus peers at 39.9x P/E and 4.9x P/S. That would be easier to accept if DOCN already had a fortress balance sheet and abundant free cash flow, but it does not. FY2025 free cash flow was only $0.1B, cash flow quality scores a weak 6/100, and leverage remains meaningful at 4.14x debt/EBITDA with $1.5B of debt. The market is underwriting not just strong growth, but smooth scaling of margins, capex, and infrastructure turn-up.
The case now depends on three things. First, AI demand has to remain strong enough to sustain the 35%+ exit rate into 2027. Second, capacity must arrive on time, because management has explicitly said it is too early to put a 2027 number out due to data-center timing and power turn-up. Third, pricing and product mix must lift cash generation, not just revenue, because inference growth alone does not solve a capital intensity problem. Those are achievable, but the stock is priced as if they are close to certain.
This is why conviction is low rather than high. A high-quality short needs operational cracks, and DOCN is not showing them. It is beating estimates, securing capacity, and gaining AI customers. But a disciplined investor does not need the company to fail to avoid the stock. At this valuation, merely good execution may not be enough.
Q4 exit growth above 35% carries into 2027, new capacity ramps on time, and AI ARR sustains triple-digit growth long enough to justify the quality-adjusted valuation.
DOCN executes on FY2026 guidance, but valuation compresses toward a more balanced growth-plus-quality framework as investors wait for proof on 2027.
AI capacity turns up slower than expected, 2027 growth stays constrained by supply, and the stock derates toward DCF and PEG-style outcomes.
Quant call (SELL) diverges from analyst consensus (Strong Buy: 6 buy / 2 hold / 0 sell) — resolve explicitly.
We suffer more often in imagination than in reality.
Forward earnings power is improving, but the market is already paying for a lot more than management has locked in. FY2026 guidance calls for $1.35-$1.40 non-GAAP EPS, which still leaves the stock on a very demanding forward multiple at the current price, while the trailing 51.64x P/E and premium 13.46x P/S assume AI growth stays hot and converts cleanly into durable cash flow. The moat is better today than it was two years ago because DOCN has carved out a clearer SMB and developer cloud niche and added differentiated AI infrastructure, but over 3-5 years it still faces stronger-capitalized hyperscalers and specialized GPU platforms. AI is helping near-term demand materially, but it also raises the capital bar, power dependence, and execution burden, so the secular story is positive for revenue and less clean for returns on capital.
- Valuation is stretched at 51.64x P/E versus 39.9x peer average, and 13.46x P/S versus 4.9x peers.
- Business momentum is real, with Q2 2026 revenue of $281M, $93M incremental ARR, and AI customer ARR of $234M, up 212% y/y.
- Balance-sheet and cash-flow support are only moderate, with debt/EBITDA 4.14x, debt/equity 1.61, and only $0.1B FCF in FY2025.
- Management raised FY2026 revenue guidance to $1.17B-$1.18B, implying about 30.5% growth, and said it expects at least 35% growth by Q4 2026.
- Execution has been consistently ahead of Street numbers, with 8 straight EPS beats and the last two at +72.9% and +65.5%.
- AI demand is scaling fast: AI customer ARR reached $234M, up 212% y/y, and inference services grew about 800% y/y with over 6,000 customers since launch.
- Capacity build is tangible, with 20 MW incremental capacity secured and total committed capacity near 155 MW, with the majority online by end-2027.
- The stock remains expensive even after pulling back from its high, at 51.64x earnings and 13.46x sales, while the quantitative method blend points to $78.57, or -46.0% versus the current price.
- Capital intensity is rising into the AI buildout, and FY2025 free cash flow was only $0.1B, producing a very weak Cash Flow Quality score of 6/100.
- Leverage is not trivial for a company still scaling capacity, with $1.5B total debt and 4.14x debt/EBITDA, even after retiring about $472M of converts.
- Management has not given formal 2027 guidance because growth depends on data-center timing and capacity turn-up, which leaves a lot of the current premium resting on execution not yet de-risked.
| Metric | Value | Context |
|---|---|---|
| Current price | $145.41 | Reference price for valuation and scenario framing |
| Quant price target | $78.57 | -46.0% vs current, Low confidence, basis: earnings_growth_blend |
| FY2025 revenue | $0.9B | +9.7% YoY, before the FY2026 AI-led acceleration |
| FY2025 EPS | $2.83 | +54.5% YoY, with operating leverage improving |
| Operating margin | 14.5% | Up from 11.7% in the prior FY |
| FY2026 revenue guide | $1.17B-$1.18B | Approximately 30.5% growth, with 35%+ Q4 exit growth |
| FY2026 adjusted EBITDA margin guide | approximately 39% | Shows strong adjusted profitability despite capacity expansion |
| FY2026 adjusted FCF margin guide | 11%-13% | Raised, but still modest relative to the stock's valuation |
| Valuation | 51.64x P/E, 13.46x P/S | Above peers at 39.9x P/E and 4.9x P/S |
| Leverage | 4.14x debt/EBITDA | $1.5B total debt, debt/equity 1.61 |
| Price action | -22.4% vs 52-week high, +43.5% vs 200-day average | Still elevated despite pullback from $187.50 high |
The biggest risk to a bearish stance is that AI demand converts into sustained 35%+ growth beyond 2026, making the current 51.64x P/E look less demanding than it appears today.
The next catalyst is Q3 2026 earnings on November 4, 2026, especially whether revenue lands within $304M-$307M and whether management can start framing 2027 capacity monetization.
Ownership is concentrated, with the top three institutions holding 71.5% and insiders at 17.5%, which can support the stock when fundamentals are working but can also amplify reversals if growth expectations reset. Short interest is meaningful at 8.86%, or 8.28M shares, but days-to-cover is only 2.6, so this is not an extreme squeeze setup. Near-dated options positioning is supportive, with positive gamma and zero-gamma at $126.45, about 12.94% below spot, which suggests current trading support but not a fundamental valuation floor.
Grew 9.7% y/y in FY2025, then accelerated sharply with FY2026 guided to $1.17B-$1.18B.
Up 212% y/y, with 85% from non-bare-metal services, showing AI demand is broadening beyond simple capacity resale.
Rose more than 12x y/y, reflecting larger multiyear contracts and improved revenue visibility.
Revenue contribution is still early, but usage grew about 800% y/y and is a key leading indicator of platform stickiness.
DOCN posted a strong Q2 and raised 2026 revenue/FCF guidance on accelerating AI demand.
Management's operating credibility has improved. On the 2024 Q3 call, the company guided FY2024 revenue to $775M-$777M, expected 2025 baseline growth in the low to mid-teens, and raised FY24 adjusted EBITDA margin guidance to 40%-41%. What followed was better than that setup suggested: FY2025 revenue reached $0.9B, up 9.7%, then FY2026 guidance jumped to $1.17B-$1.18B, about 30.5% growth, with a 35%+ Q4 2026 exit rate as AI demand accelerated. The hit to credibility is that cash conversion has not scaled as cleanly as growth, with FY2025 FCF only $0.1B, and formal 2027 guidance is still absent because capacity timing remains the gating item. Even so, the earnings record is hard to dismiss, with 8 straight EPS beats, including +72.9% in August 2026 and +65.5% in May 2026, and key product and data-center milestones such as Richmond and Kansas City launching early while Memphis remains on track for 2H26.
With our meaningful progress and momentum, we are again raising our full year 2026 outlook. We now expect revenue growth of approximately 30% for the full year 2026 and to reach at least 35% growth by Q4 of 2026.
For the third quarter of 2026, we expect revenue of $304 million to $307 million, representing 32% to 34% year-over-year growth. We project adjusted EBITDA margins of 38% to 39% and non-GAAP diluted net income per share of $0.28 to $0.30 on approximately 126.5 million weighted average fully diluted shares.
For the full year 2026, we expect revenue of $1.17 billion to $1.18 billion, representing approximately 30.5% year-over-year growth with an exit growth rate of 35% or more in Q4. We expect adjusted EBITDA margins of approximately 39%, non-GAAP diluted EPS of $1.35 to $1.40 and adjusted free cash flow margin of 11% to 13%, an increase to our prior guide.
As we previewed several weeks ago, Q2 was another strong quarter for DigitalOcean. We were above guidance on every key metric.
We're very bullish, and we expect there to be additional upside. We're just -- it's too early to put a number on it.
DOCN's edge is not scale, it is focus. It serves developers, startups, and smaller enterprises that want simpler cloud infrastructure and increasingly AI tooling without the complexity of hyperscalers, and the $894M RPO plus record $93M incremental ARR suggest that value proposition is resonating with larger customers too. The moat is real but not impregnable: product simplicity, community, and customer fit are durable advantages, while core infrastructure and GPU access remain easier for well-capitalized rivals to replicate over time.
Capital allocation is shifting toward capacity first. FY2025 produced $0.1B FCF on $0.1B capex, with no buybacks and no dividend, which is sensible given the need to fund AI infrastructure and data-center buildout. Management also improved the liability side by retiring about $472M of 2030 converts with minimal cash use and dilution, but with $1.5B debt and 4.14x debt/EBITDA, there is little room for sloppy spending.
DOCN rates SELL at Low conviction. The company is executing, the AI demand signal is real, and management has earned more credibility than it had in 2024. But the stock still asks investors to pay a steep premium now for growth that depends on capacity deployment, cash-flow scaling, and a 2027 outlook management has not yet quantified. A more positive stance would require either a materially lower entry price or proof that FY2026's 35%+ exit growth converts into durable 2027 earnings and cash flow without stretching the balance sheet further.
≣ Full research note tap to expand
Executive Summary
SELL, Low conviction. DOCN rates a SELL at Low conviction. The company is delivering real fundamental improvement, with FY2026 revenue guided to $1.17B-$1.18B, 35%+ Q4 exit growth, and repeated earnings beats, but the stock trades at 51.64x P/E and 13.46x sales, both well above peers despite leverage of 4.14x debt/EBITDA and still-limited free cash flow of $0.1B in FY2025. This is not a broken business call, it is a price call.
Investment Thesis
DOCN is running better than it was two years ago. The company has moved from a steady-growth cloud niche story into an AI-capacity and inference demand story, and the numbers show it. Q2 revenue was $281M, above guidance. Incremental ARR was $93M, a record. AI customer ARR hit $234M, up 212% y/y. Management raised FY2026 revenue guidance to $1.17B-$1.18B and now expects 35%+ growth by Q4 2026. This is not a case of deteriorating operations or missed guidance.
The problem is the stock price. At $145.41, the market is paying a valuation that leaves little room for friction. The stock sits at 51.64x earnings and 13.46x sales, both rich versus peers at 39.9x P/E and 4.9x P/S. That would be easier to accept if DOCN already had a fortress balance sheet and abundant free cash flow, but it does not. FY2025 free cash flow was only $0.1B, cash flow quality scores a weak 6/100, and leverage remains meaningful at 4.14x debt/EBITDA with $1.5B of debt. The market is underwriting not just strong growth, but smooth scaling of margins, capex, and infrastructure turn-up.
The case now depends on three things. First, AI demand has to remain strong enough to sustain the 35%+ exit rate into 2027. Second, capacity must arrive on time, because management has explicitly said it is too early to put a 2027 number out due to data-center timing and power turn-up. Third, pricing and product mix must lift cash generation, not just revenue, because inference growth alone does not solve a capital intensity problem. Those are achievable, but the stock is priced as if they are close to certain.
This is why conviction is low rather than high. A high-quality short needs operational cracks, and DOCN is not showing them. It is beating estimates, securing capacity, and gaining AI customers. But a disciplined investor does not need the company to fail to avoid the stock. At this valuation, merely good execution may not be enough.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $145.41 | Reference price for valuation and scenario framing |
| Quant price target | $78.57 | -46.0% vs current, Low confidence, basis: earnings_growth_blend |
| FY2025 revenue | $0.9B | +9.7% YoY, before the FY2026 AI-led acceleration |
| FY2025 EPS | $2.83 | +54.5% YoY, with operating leverage improving |
| Operating margin | 14.5% | Up from 11.7% in the prior FY |
| FY2026 revenue guide | $1.17B-$1.18B | Approximately 30.5% growth, with 35%+ Q4 exit growth |
| FY2026 adjusted EBITDA margin guide | approximately 39% | Shows strong adjusted profitability despite capacity expansion |
| FY2026 adjusted FCF margin guide | 11%-13% | Raised, but still modest relative to the stock's valuation |
| Valuation | 51.64x P/E, 13.46x P/S | Above peers at 39.9x P/E and 4.9x P/S |
| Leverage | 4.14x debt/EBITDA | $1.5B total debt, debt/equity 1.61 |
| Price action | -22.4% vs 52-week high, +43.5% vs 200-day average | Still elevated despite pullback from $187.50 high |
Financial Strength
Financial strength is adequate, not clean. Profitability is moving the right way, with 14.5% operating margin in FY2025 and FY2026 adjusted EBITDA margin guided around 39%, but the balance sheet still carries real leverage at 4.14x debt/EBITDA and $1.5B of debt. The convert retirement was a smart move and reduces some future overhang, yet the bigger issue is cash conversion: $0.1B FCF in FY2025 and a Cash Flow Quality score of 6/100 mean the company has not yet translated its AI momentum into a level of internally funded flexibility that would justify a premium valuation on its own.
Competitive Position
DOCN's edge is not scale, it is focus. It serves developers, startups, and smaller enterprises that want simpler cloud infrastructure and increasingly AI tooling without the complexity of hyperscalers, and the $894M RPO plus record $93M incremental ARR suggest that value proposition is resonating with larger customers too. The moat is real but not impregnable: product simplicity, community, and customer fit are durable advantages, while core infrastructure and GPU access remain easier for well-capitalized rivals to replicate over time.
Management & Guidance
Management's latest guidance is strong and, based on the recent beat pattern, reasonably credible. For Q3 2026, the company expects $304M-$307M of revenue, 38%-39% adjusted EBITDA margin, and $0.28-$0.30 of non-GAAP EPS. For FY2026, management guided to $1.17B-$1.18B revenue, roughly 39% adjusted EBITDA margin, $1.35-$1.40 non-GAAP EPS, and 11%-13% adjusted free cash flow margin, all raised after a quarter it described as above guidance on every key metric. The caveat is that management still will not frame 2027 formally because capacity timing matters, so credibility on the next leg of growth remains partly unproven rather than fully established.
Segment Analysis
- Total company revenue ($0.9B in FY2025): Grew 9.7% y/y in FY2025, then accelerated sharply with FY2026 guided to $1.17B-$1.18B.
- AI customer ARR ($234M): Up 212% y/y, with 85% from non-bare-metal services, showing AI demand is broadening beyond simple capacity resale.
- RPO ($894M): Rose more than 12x y/y, reflecting larger multiyear contracts and improved revenue visibility.
- Inference services (6,000+ customers): Revenue contribution is still early, but usage grew about 800% y/y and is a key leading indicator of platform stickiness.
Capital Allocation
Capital allocation is shifting toward capacity first. FY2025 produced $0.1B FCF on $0.1B capex, with no buybacks and no dividend, which is sensible given the need to fund AI infrastructure and data-center buildout. Management also improved the liability side by retiring about $472M of 2030 converts with minimal cash use and dilution, but with $1.5B debt and 4.14x debt/EBITDA, there is little room for sloppy spending.
Management Execution & Track Record
Management's operating credibility has improved. On the 2024 Q3 call, the company guided FY2024 revenue to $775M-$777M, expected 2025 baseline growth in the low to mid-teens, and raised FY24 adjusted EBITDA margin guidance to 40%-41%. What followed was better than that setup suggested: FY2025 revenue reached $0.9B, up 9.7%, then FY2026 guidance jumped to $1.17B-$1.18B, about 30.5% growth, with a 35%+ Q4 2026 exit rate as AI demand accelerated. The hit to credibility is that cash conversion has not scaled as cleanly as growth, with FY2025 FCF only $0.1B, and formal 2027 guidance is still absent because capacity timing remains the gating item. Even so, the earnings record is hard to dismiss, with 8 straight EPS beats, including +72.9% in August 2026 and +65.5% in May 2026, and key product and data-center milestones such as Richmond and Kansas City launching early while Memphis remains on track for 2H26.
Positioning & Flows
Ownership is concentrated, with the top three institutions holding 71.5% and insiders at 17.5%, which can support the stock when fundamentals are working but can also amplify reversals if growth expectations reset. Short interest is meaningful at 8.86%, or 8.28M shares, but days-to-cover is only 2.6, so this is not an extreme squeeze setup. Near-dated options positioning is supportive, with positive gamma and zero-gamma at $126.45, about 12.94% below spot, which suggests current trading support but not a fundamental valuation floor.
Bull Case
- Management raised FY2026 revenue guidance to $1.17B-$1.18B, implying about 30.5% growth, and said it expects at least 35% growth by Q4 2026.
- Execution has been consistently ahead of Street numbers, with 8 straight EPS beats and the last two at +72.9% and +65.5%.
- AI demand is scaling fast: AI customer ARR reached $234M, up 212% y/y, and inference services grew about 800% y/y with over 6,000 customers since launch.
- Capacity build is tangible, with 20 MW incremental capacity secured and total committed capacity near 155 MW, with the majority online by end-2027.
Bear Case
- The stock remains expensive even after pulling back from its high, at 51.64x earnings and 13.46x sales, while the quantitative method blend points to $78.57, or -46.0% versus the current price.
- Capital intensity is rising into the AI buildout, and FY2025 free cash flow was only $0.1B, producing a very weak Cash Flow Quality score of 6/100.
- Leverage is not trivial for a company still scaling capacity, with $1.5B total debt and 4.14x debt/EBITDA, even after retiring about $472M of converts.
- Management has not given formal 2027 guidance because growth depends on data-center timing and capacity turn-up, which leaves a lot of the current premium resting on execution not yet de-risked.
Valuation & Price Target
Engine price target $78.57 (-46% vs current), Low confidence.
- P/E Multiple: $90.09 (28% weight)
- PEG (growth-adjusted): $36.67 (20% weight)
- P/S Multiple: $41.61 (17% weight)
- Quality-adjusted: $147.74 (20% weight)
- DCF: $35.46 (5% weight)
This rating aligns with the quantitative baseline of SELL, though the call is low conviction because the business trend is stronger than a simple backward-looking screen would imply. The reason not to upgrade despite strong execution is valuation: $145.41 sits far above the engine's $78.57 target, and the stock trades at 51.64x P/E and 13.46x P/S against peer averages of 39.9x and 4.9x. That premium might be defendable if balance-sheet risk were low and free cash flow were already scaling, but 4.14x debt/EBITDA, $1.5B debt, and just $0.1B FCF in FY2025 argue otherwise. Sell-side consensus remains Strong Buy with 6 buy / 2 hold / 0 sell, but that is low-signal context here because the debate is less about whether fundamentals are improving and more about how much of that improvement is already in the stock.
Risk Assessment
Risk score 55/100 (Moderate). The biggest risk to a bearish stance is that AI demand converts into sustained 35%+ growth beyond 2026, making the current 51.64x P/E look less demanding than it appears today.
The Bottom Line
DOCN rates SELL at Low conviction. The company is executing, the AI demand signal is real, and management has earned more credibility than it had in 2024. But the stock still asks investors to pay a steep premium now for growth that depends on capacity deployment, cash-flow scaling, and a 2027 outlook management has not yet quantified. A more positive stance would require either a materially lower entry price or proof that FY2026's 35%+ exit growth converts into durable 2027 earnings and cash flow without stretching the balance sheet further.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr